Back to results
US 2021/0061853 A1Published application
Crystalline bis- and tris-hydrochloride salt of elamipretide
AssigneeStealth BioTherapeutics Inc.
InventorScott M. Duncan
Life of this patent
Estimating the term…
Abstract
Disclosed are crystalline forms of the bis- and tris-(hydrochloride) salts of D-Arg-Tyr(2,6-DiMe)-Lys-Phe-NH2, which is also known as MTP-131.
Claims5
1-11. (canceled)
A process for making a pharmaceutical composition comprising Compound (I),
- comprising dissolving a crystalline form of a bis-(hydrochloride) salt of Compound (I);
- wherein said crystalline form has peaks in its XRPD pattern at values of two theta (° 2θ) of:
- 6.4, 9.8, 13.1, 16.9, 19.1, and 29.7.
A process for making a pharmaceutical composition comprising Compound (I),
- comprising dissolving a crystalline form of a tris-(hydrochloride) salt of Compound (I);
- wherein said crystalline form has peaks in its XRPD pattern at values of two theta (° 2θ) of:
- 8.1, 11.5, 15.6, 15.9, 22.1, 23.0, and 27.4.
Dependencies are inferred from the claim text.